Grove Collaborative (GROV) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Net revenue for Q1 2026 was $36.2 million, down 16.8%–17% year-over-year, but ahead of expectations and marking the expected revenue trough; positive adjusted EBITDA of $0.3 million was achieved for the second consecutive quarter.
Gross margin expanded to 54.8%–55%, up 180 basis points year-over-year, driven by targeted promotions, loyalty program adoption, and a shift from broad discounting.
Net loss narrowed to $1.0 million from $3.5 million year-over-year, reflecting cost reductions and improved gross margin.
Customer experience and repeat order rates recovered to pre-migration levels following platform disruptions, supporting a measured re-acceleration of advertising investment.
Strategic focus remains on profitable DTC growth, deepening authority in human health, and responsible advertising spend.
Financial highlights
Gross margin improved to 54.8%–55%, up 180 basis points year-over-year, aided by targeted promotions and loyalty program incentives.
Adjusted EBITDA was $0.3 million (0.8% margin), compared to -$1.6 million (-3.7% margin) in the prior year.
Net loss margin improved to (2.8)% from (8.1)% year-over-year.
Operating cash flow was -$0.7 million, a significant improvement from -$6.9 million in the prior year, mainly due to inventory build and better working capital management.
Cash, cash equivalents, and restricted cash totaled $10.4 million at quarter-end.
Outlook and guidance
Full-year 2026 net revenue guidance raised to $142.5–$152.5 million, with adjusted EBITDA expected at breakeven to positive low single-digit millions.
Q1 2026 is expected to be the revenue trough, with sequential improvement anticipated in each subsequent quarter.
Guidance reflects improved customer cohort performance, acquisition efficiency, and platform stability.
Latest events from Grove Collaborative
- Shareholders will vote virtually on director elections and auditor ratification for 2026.GROV
Proxy filing28 Apr 2026 - Director elections, auditor ratification, and ESG oversight highlight this year's proxy agenda.GROV
Proxy filing28 Apr 2026 - Positive adjusted EBITDA and margin gains in Q4; 2026 targets breakeven EBITDA and revenue growth.GROV
Q4 20255 Mar 2026 - Q2 2024 saw positive Adjusted EBITDA, improved margins, and a $42M debt paydown amid revenue decline.GROV
Q2 20241 Feb 2026 - Break-even EBITDA, narrowed loss, and positive cash flow as focus shifts to DTC and debt reduction.GROV
Q3 202414 Jan 2026 - Q4 2024 saw revenue growth, debt reduction, and positive EBITDA, with cautious 2025 guidance.GROV
Q4 202426 Dec 2025 - Up to 7.76M shares registered for resale by a major investor; no proceeds to the company.GROV
Registration Filing16 Dec 2025 - Shareholders will vote on director elections and auditor ratification at the 2025 annual meeting.GROV
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and major governance updates highlight this year's proxy.GROV
Proxy Filing2 Dec 2025